• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Catalyst Pharmaceutical Partners Inc. (CPRX)

    -NasdaqCM
    3.96 Up 0.02(0.51%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.94
    Open:3.95
    Bid:N/A
    Ask:4.25 x 30000
    1y Target Est:7.60
    Beta:1.91
    Earnings Date:Aug 12 - Aug 17 (Est.)
    Day's Range:3.90 - 4.00
    52wk Range:1.95 - 5.10
    Volume:347,019
    Avg Vol (3m):922,217
    Market Cap:324.07M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CPRX

    Comparison

    Symbol% ChgMkt Cap
    CPRXUp 0.51%324.07M
    SNYDown 1.01%132.66B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.38
    Quarterly EPS Est (Jun-15) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Catalyst Pharmaceutical Partners, Inc., a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting rare (orphan) neurological diseases and disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback